返回 Agenda
Session Chair(s)
Helen Li, MD, MBA
Director, Emerging Market QA Asia Lead
Pfizer Medical, China
Speaker(s)
CFDA Updates
Representative Invited
China
Update from FDA on GCP Compliance
Leslie Ball, MD
FDA, United States
Assistant Commissioner and Deputy Director, OIP, OC
Facts and Figures of GCP Inspections Conducted - EMA Perspective
David Cockburn
European Medicines Agency, Netherlands
Head of Manufacturing and Quality Compliance Service
GCP Compliance, Challenges, Strategies and Experiences
Vincent Yeung, PHD, MBA, RPH
MHRA, United Kingdom
GCP Operations Manager, Inspection, Enforcement, and Standards Division